These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14974421)

  • 1. FDA grants approval to fosamprenavir calcium.
    AIDS Alert; 2004 Jan; 19(1):11-2. PubMed ID: 14974421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA approves Lexiva.
    IAPAC Mon; 2003 Nov; 9(11):280. PubMed ID: 14989187
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA approves new formulation of Lexiva.
    AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 5. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 6. Lexiva (fosamprenavir) approved.
    AIDS Treat News; 2003 Oct; (395):2. PubMed ID: 14666909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 9. [Individualized therapy with fosamprenavir/r. A PI suitable in liver problems].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():60-1. PubMed ID: 19031566
    [No Abstract]   [Full Text] [Related]  

  • 10. Four posters add to our knowledge of Lexiva.
    Proj Inf Perspect; 2008 Dec; (47):7-8. PubMed ID: 19227558
    [No Abstract]   [Full Text] [Related]  

  • 11. [Maintaining independence. New protease inhibitor receives drug approval recommendation].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():84-5. PubMed ID: 15373062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Potent new protease inhibitor. Boostered protease inhibitors--a separate class of drugs].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():40-1. PubMed ID: 15011585
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. Fosamprenavir label is updated.
    AIDS Alert; 2008 Feb; 23(2):21-2. PubMed ID: 18578033
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HIV agents. Saquinavir with fosamprenavir.
    TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17219609
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [No selection of mutations. 908 raises genetic resistance barrier].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():41. PubMed ID: 15011586
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. Agenerase product label changed.
    AIDS Alert; 2002 Oct; 17(10):131. PubMed ID: 12400469
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA approves new PI.
    Gadd C
    IAPAC Mon; 2006 Jun; 12(6):174. PubMed ID: 17233103
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects.
    McRae M; Clay PG; Anderson PL; Glaros AG
    Pharmacotherapy; 2009 Aug; 29(8):937-42. PubMed ID: 19637947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.
    Gathe JC; Wood R; Sanne I; DeJesus E; Schürmann D; Gladysz A; Garris C; Givens N; Elston R; Yeo J
    Clin Ther; 2006 May; 28(5):745-54. PubMed ID: 16861096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.